Indena

Activities: Ingredients Research & Development Nutraceutical

Trending Articles

  1. Pfizer and BioNTech’s COMIRNATY COVID-19 vaccine wins FDA approval for seniors and high-risk individuals The COVID-19 vaccines by Pfizer and BioNTech are based on BioNTech’s proprietary mRNA technology and were developed by both companies
  2. Indena and TCG GreenChem join forces to advance next-generation ADC technologies Indena and TCG GreenChem are pleased to announce a new strategic collaboration aimed at accelerating the development of innovative and market-ready payload-linkers: the key...
  3. SGD Pharma acquires Alphial Srl in a strategic step forward SGD Pharma is pleased to announce an agreement with Italian Private Equity firm Entangled Capital to acquire Alphial Srl, a leading producer of tubular vials and ampoules...
  4. When the chemistry is right: Vetter expands capacities with a pure water generator from Pharmatec The production of injectable active pharmaceutical ingredients (APIs) is a highly complex process that leaves no room for error
  5. Meet Navetta: new approach to safety testing of drugs and particles Turn inhalation research upside down

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

Related Content

Research & Development

Indena and TCG GreenChem join forces to advance next-generation ADC technologies

Indena and TCG GreenChem are pleased to announce a new strategic collaboration aimed at accelerating the development of innovative and market-ready payload-linkers: the key component of antibody-drug conjugates (ADCs)
Pharmaceutical

CDMO services and innovative products for pharmaceutical industry

The Italian company stands as a reliable partner for pharmaceutical and biotech clients in the Japanese market
Ingredients

Indena becomes first API manufacturer to receive European CEP certification

Its CBD extract is the first to receive the European Pharmacopoeia Certificate of Eligibility from the European Directorate for the Quality of Medicines (EDQM)
Manufacturing

Indena showcases its CDMO services and HPAPI capabilities at CPHI 2024

The company will display its range of high-potency APIs, as well as its ADC and linker payload development and manufacturing capabilities
Manufacturing

Indena’s CDMO services: a full range of capabilities, innovative equipment and professional expertise

As a supplier of contract services since the 1990s, being a CDMO is not just about being a custom development and manufacturing organisation, it also represents a Curiosity for science, the Development of knowledge, Mastering complexity and an Obsession for quality

Indena at DCAT 2024: a new generation of CDMO services

Leveraging on its analytical, development and manufacturing capabilities, Indena positions its services in a high added value segment, producing complex molecules from early stage to commercialisation
Finance

IDB Holding invests in Lab Evo, a start-up for digitisation in the health sector

The group, to which Indena and Scharper both belong, confirms its attention devoted to innovative solutions for people’s health
Subscribe now